These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11796767)

  • 1. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.
    Hensiek AE; Sawcer SJ; Feakes R; Deans J; Mander A; Akesson E; Roxburgh R; Coraddu F; Smith S; Compston DA
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):184-7. PubMed ID: 11796767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
    Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
    Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
    Aláez C; Corona T; Ruano L; Flores H; Loyola M; Gorodezky C
    Acta Neurol Scand; 2005 Nov; 112(5):317-22. PubMed ID: 16218914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy.
    Perini P; Tagliaferri C; Belloni M; Biasi G; Gallo P
    Neurology; 2001 Jul; 57(1):158-9. PubMed ID: 11445652
    [No Abstract]   [Full Text] [Related]  

  • 5. Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran.
    Kalanie H; Kamgooyan M; Sadeghian H; Kalanie AR
    Mult Scler; 2000 Oct; 6(5):317-9. PubMed ID: 11064440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
    Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
    Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
    Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
    da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
    J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
    Rasmussen HB; Kelly MA; Clausen J
    Mult Scler; 2001 Apr; 7(2):91-3. PubMed ID: 11424637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
    Ganesvaran G; Greer JM; Pender MP
    Mult Scler; 2009 Jun; 15(6):763-6. PubMed ID: 19482865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS.
    Cocco E; Sotgiu A; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Contu P; Marrosu MG
    Neurology; 2005 Feb; 64(3):564-6. PubMed ID: 15699400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of HLA-DR15 and intermediate uveitis.
    Tang WM; Pulido JS; Eckels DD; Han DP; Mieler WF; Pierce K
    Am J Ophthalmol; 1997 Jan; 123(1):70-5. PubMed ID: 9186099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.